Hillhouse Capital Management - NABRIVA THERAPEUTICS AG ownership

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of NABRIVA THERAPEUTICS AG
ValueSharesWeighting
Q2 2017$7,193,000
-12.7%
686,400
-0.1%
0.11%
-30.6%
Q1 2017$8,236,000
+97.7%
686,900
-1.9%
0.16%
+72.0%
Q4 2016$4,165,000700,0000.09%
Other shareholders
NABRIVA THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 4,021,559$23,968,0007.90%
Omega Fund Management, LLC 1,145,890$6,830,0005.54%
ACUTA CAPITAL PARTNERS, LLC 706,383$4,210,0001.57%
Novo Holdings A/S 2,326,544$13,866,0001.32%
FT Options LLC 83,055$494,0000.57%
EcoR1 Capital, LLC 264,773$1,578,0000.50%
Boxer Capital, LLC 176,710$1,053,0000.41%
Rock Springs Capital Management LP 525,000$3,124,0000.21%
Orbimed Advisors 1,677,940$10,001,0000.13%
Hillhouse Capital Management 700,000$4,165,0000.09%
View complete list of NABRIVA THERAPEUTICS AG shareholders